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Chromosome 5q33 is a region that has previously shown good evidence of linkage to schizophrenia, with four
LOD scores 13.00 in independent linkage studies. We studied 450 unrelated white English, Irish, Welsh, and Scottish
research subjects with schizophrenia and 450 ancestrally matched supernormal controls. Four adjacent markers at
the 5′ end of the Epsin 4 gene showed significant evidence of linkage disequilibrium with schizophrenia. These
included two microsatellite markers, D5S1403 ( ) and AAAT11 ( ), and two single-nucleotide–Pp .01 Pp .009
polymorphism markers within the Epsin 4 gene, rs10046055 ( ) and rs254664 ( ). A series ofPp .007 Pp .01
different two- and three-marker haplotypes were also significantly associated with schizophrenia, as confirmed with
a permutation test (HapA, ; HapB, ; HapC, ; and HapD, ). The Epsin 4 genePp .004 Pp .0005 Pp .007 Pp .01
encodes the clathrin-associated protein enthoprotin, which has a role in transport and stability of neurotransmitter
vesicles at the synapses and within neurons. A genetically determined abnormality in the structure, function, or
expression of enthoprotin is likely to be responsible for genetic susceptibility to a subtype of schizophrenia on
chromosome 5q33.3.
Important genetic effects in the susceptibility to schizo-
phrenia have now been established by twin, adoption,
genetic-linkage, and allelic-association studies. Linkage
studies have proven that there is heterogeneity of linkage
or locus heterogeneity for different genetic subtypes of
schizophrenia. We originally obtained LOD scores 13.00
showing linkage to the first schizophrenia locus (SCZD1
[MIM 181150]) on chromosome 5 in a sample of 23
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highly selected large multiplex families, by use of a lim-
ited set of RFLP markers that were not well localized
but were thought to be within the cytogenetic region
5q11-12 (Sherrington et al. 1988; Kalsi et al. 1999). Later,
we completed a genome linkage scan in a subsample of
these families (Gurling et al. 2001) but found two positive
regions of linkage to schizophrenia that were adjacent
on either side of the original 5q11-12 region. In this
later genome scan, we used better localized markers that
were evenly spread along the whole chromosome 5.
Some of the families that produced positive LOD scores
at 5q11-12 in the original study (Sherrington et al. 1988)
then showed linkage near the centromere on chromo-
some 5, with a LOD score of 2.5, and other families
showed linkage to markers on the long arm in the 5q22-
33 region (Gurling et al. 2001).
The more distal of the two regions we implicated was
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at 5q22-34, where we obtained a LOD score of 3.6 (nomi-
nal ). The chromosome 5q22-34 region hadPp .0001
also been found to be linked to schizophrenia in a sample
of Irish families (Straub et al. 1997), with a heterogeneity
LOD score of 3.35 near locus D5S804 ( ).Pp .0002
Subsequently, analysis of a single large kindred from
Palau, Micronesia, resulted in a LOD score of 3.4 and
showed linkage to schizophrenia with markers in the
5q22-31 region (Devlin et al. 2002). Later, a study of
Finnish families also found linkage to schizophrenia, with
a LOD score of 3.56, at 5q22-31 (Paunio et al. 2001).
A collaborative study of the 5q22-31 region (Levinson
1999) found that four of eight independent linkage sam-
ples of families with schizophrenia resulted in LOD scores
11.00. For example, analysis of a sample of German
families resulted in a LOD score of 1.8 at 5q22-31, at
marker D5S399 (Schwab et al. 1997).
These studies suggest that there must be at least two—
and possibly three or more—different regions of chromo-
some 5 that harbor susceptibility loci for schizophrenia.
The evidence implicating the more distal region of chro-
mosome 5 at 5q33 is derived from four independent
linkage studies that report LOD scores 13.00. We at-
tempted to identify exactly which gene might be in-
volved, by the detection of linkage disequilibrium (LD)
in a case-control genetic-association study, using mark-
ers we had previously found to show maximal evidence
of linkage to schizophrenia.
We recruited a sample of 450 volunteers with schizo-
phrenia and 450 controls from London and southern
England. All subjects were included only if both parents
were of English, Irish, Welsh, or Scottish descent and if
three of four grandparents were of the same descent.
One grandparent was allowed to be of other white Eu-
ropean origin but not of Jewish or non–European Union
(EU) ancestry (on the basis of the EU countries before
the recent enlargement). U.K. National Health Service
(NHS) multicenter and local research ethics committee
approval was obtained, and all subjects signed an ap-
proved consent form after reading an information sheet.
All 450 schizophrenic research subjects had been diag-
nosed and assessed by NHS psychiatrists as part of rou-
tine clinical diagnosis and treatment. Research subjects
with short-term drug-induced psychoses, learning dis-
abilities, head injuries, and other symptomatic psychoses
were excluded from the present study. Research subjects
were selected on the basis of having an International
Classification of Diseases version 10 diagnosis of schizo-
phrenia recorded in the NHS medical case notes. That
information together with personal, medical, and psy-
chiatric histories and all other available information were
taken into consideration to complete data collection and
interviewing with the Schizophrenia and Affective Dis-
orders Schedule–Lifetime Schedule (SADS-L) interview
(Spitzer and Endicott 1977). The SADS-L protocol ex-
pects data items to be recorded accurately from previous
medical records and does not rely on the accuracy of
statements made during the interview by mentally ill
research subjects. After the SADS-L interview was com-
pleted using all sources of information, the subject in-
dividuals received the diagnosis of schizophrenia in ac-
cordance with the probable level of the Research Diag-
nostic Criteria (RDC). The “supernormal” control sub-
jects were also interviewed in accordance with SADS-L
guidelines, by use of the initial clinical screening ques-
tions, and were selected on the basis of having no family
history of schizophrenia, alcoholism, or bipolar disorder
and having no past or present personal history of any
RDC-defined mental disorder.
Genomic DNA was extracted from frozen whole-blood
samples by use of a standard cell lysis, proteinase K
digestion, and phenol/chloroform ethanol precipitation
method. All DNA samples were quantified with pico
green by laser fluorimetry. The first set of five markers
genotyped was selected on the basis of having shown
maximal linkage and minimal recombination fraction to
a chromosome 5q33 schizophrenia-susceptibility locus,
with the assumption of admixture, in our previous ge-
nome linkage scan in large kindreds with schizophrenia.
Specific loci were not targeted by genotyping markers next
to known genes. The microsatellite marker AAAT11 was
identified, formatted, and genotyped for the present study
and was amplified with the primers (forward) CTAGTT-
GGGAGGCTGAGGTG and (reverse) AAGAGGGAGC-
CTCAATCTGG. Primer sequences for PCR amplifica-
tion of the microsatellite marker D5S1403 and the SNPs
were obtained from ENSEMBL, the University of Cali-
fornia–Santa Cruz (UCSC) Genome Bioinformatics Web
site, or the National Center for Biotechnology Informa-
tion SNP Database. PCR amplification of microsatellite
markers was performed using an M13-tailed primer and
a second nontailed oligonucleotide primer. A third uni-
versal M13 sequence primer labeled with infrared dye
IRD 700 or IRD 800 was used to hybridize against the
M13-tailed locus-specific primer. Microsatellite marker–
fragment sizes were separated and visualized using dual
argon laser LiCor 4200L sequencers. Genotyping was
performed with the SAGA2 genotyping software and was
checked by eye. Allele calling by SAGA2 was checked
by a second independent person, blind to diagnosis. The
genotype data were automatically stored in a database.
Any genotypes that were discrepant between the two
checkers were PCR amplified and were genotyped again.
SNPs were determined by the Amplifluor SNP geno-
typing method, as modified by K Biosciences. Of samples
on each microtiter plate, 17% were duplicated to detect
error and to confirm the reproducibility of genotypes.
The data were then analyzed to confirm Hardy-Wein-
berg equilibrium (HWE). Markers with lack of HWE in
the control group were rejected, and genotyping was
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Table 2
Results of Tests of Haplotypic Association with Schizophrenia at the Epsin 4 Gene Locus
No. of Markers and Haplotype (Allele) x2 Pa
2 (440 controls; 396 cases):
HapA: rs254664 (T) and rs10046055 (A)b 13.2 .004
HapB: rs1186930 (T) and rs10046055 (A)b 18.3 .0005
HapC: rs10046055 (A) and AAAT11 (252 bp)b 21.2 .007
3 (442 controls; 408 cases):
HapD: rs254664 (T), rs10046055 (A), and AAAT11 (252 bp)b 28.1 .01
HapE: rs1145603 (T), rs10046055 (A), and AAAT11 (252 bp)b 28.3 .01
a Haplotype permutation test empirical P, on the basis of 99,999 permutations.
b Most likely to be specific alleles that show association in each haplotype.
Table 3
Results of Pairwise LD Statistics between All Pairs of Associated Markers
MARKER
ABSOLUTE VALUE OF D′ AND LD P VALUESa
rs254664 rs1186930 rs10046055 AAAT11 D5S1403 D5S1400
rs254664 .992 .220 .395 .414 .044
rs1186930 !.00001 .242 .058 .383 .057
rs10046055 !.00001 !.00001 .883 .252 .339
AAAT11 !.00001 !.00001 !.00001 .238 .357
D5S1403 !.00001 !.00001 .006 .157 .220
D5S1400 !.00001 .856 !.00001 !.00001 !.00001
a D′ values shown above the diagonal; P values shown below diagonal.
repeated. Before association analysis, genotype data for
each 96-well microtiter plate were analyzed for LD,
by use of GENECOUNTING/LDPAIRS, to check that
closely linked markers had consistent LD relationships
on each plate.
Next, these data were analyzed for allelic association
with schizophrenia by use of CLUMP, which employs
an empirical Monte Carlo test of significance and which
does not require correction for multiple alleles (Sham
and Curtis 1995). Subtests of the CLUMP program are
T1, Pearson’s x2 statistic of the “raw” contingency table;
T2, the x2 statistic of a table with rare alleles grouped
together to prevent small expected cell counts; T3, the
largest of the x2 statistics of tables, each of which2# 2
compares one allele with the rest grouped together; and
T4, the largest of the x2 statistics of all possible 2# 2
tables, comparing any combination of alleles with the
rest. The genotypes were then analyzed for marker-to-
marker LD and for haplotypic association with schizo-
phrenia by use of GENECOUNTING/LDPAIRS, which
computes D′ and Cramer’s V tests of LD and maximum-
likelihood estimates of haplotype frequencies from phase-
unknown case-control data (Zhao et al. 2000, 2002).
The significance of any overall haplotype association with
schizophrenia was computed using permutation testing.
Fifteen genetic markers at chromosomal loci thought to
be not involved in schizophrenia were genotyped in a
subset of the sample (200 cases and 300 controls) and
were analyzed to detect genetic heterogeneity between
cases and controls, to confirm that the samples were
genetically well matched. In addition, a statistical test
(CHECKHET) for detecting subjects with atypical ge-
netic background was employed (Curtis et al. 2002).
No evidence of genetic heterogeneity between cases and
controls was found from using the reference markers. The
CHECKHET test detected two subjects with schizophre-
nia with abnormal genotypes; these were excluded from
further study before any chromosome 5 markers were
genotyped. After five microsatellite markers—D5S1480,
D5S1507, D5S1499, D5S820, and D5S1403—had been
genotyped, a positive allelic association was found with
D5S1403, as shown in table 1 (CLUMP T4, ).Pp .01
Therefore, 11 additional markers close to D5S1403 were
selected and genotyped. One of these 11 markers was the
microsatellite marker AAAT11, which was 40 kb from
D5S1403. This marker also showed significant evidence
of association with schizophrenia, with an empirical P
value of .007. Two of four SNP markers within the Epsin
4 gene (rs10046055 [ ] and rs254664 [Pp .002 Pp
]) were also found to be associated with schizophrenia..02
Flanking markers on each side of the Epsin 4 gene did
not show association.
The allele frequencies, positions on chromosome 5 for
the Epsin 4 gene, and markers showing significant evi-
dence or a trend toward association with schizophrenia
are shown in tables 1 and 2, in their order on chro-
mosome 5q, in accordance with the June 2004 release
of the UCSC Genome Browser. Two-marker haplotype
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HapA (see table 2), derived from combining the SNP
markers rs254664 and rs10046055, showed association
with schizophrenia, on the basis of permutation testing
( ). Significant association verified through per-Pp .004
mutation testing ( ) was also found with thePp .0005
SNP markers rs1186930 and rs10046055 when com-
bined into haplotype HapB and with the markers
rs10046055 and AAAT11 in HapC. Two three-marker
haplotypes (HapD and HapE) that combined the micro-
satellite marker ATTT11 with two of the three SNP
markers rs254664, rs10046055, and rs1145603 also
showed significant association (permutation test Pp
and .007, respectively). Each of the markers that.001
showed association with schizophrenia was in strong LD
( ) with one or more of the other associatedP ! .00001
markers, as shown in table 3.
The five originally genotyped markers were selected
as the closest markers to the chromosome 5q33 linkage
peak obtained in our previously published genome an-
alysis of large schizophrenic kindreds. One of these mark-
ers showed some evidence for association; hence, new
markers nearby were genotyped. Individually, some of
these markers produced more highly significant evidence
for association. Because these markers are in LD with
each other, it is not possible to state the overall signifi-
cance of all the tests for association obtained from in-
dividual markers and from marker combinations, but,
together, the results do indicate that a locus conferring
susceptibility to schizophrenia is likely to be present in
this narrowly defined region.
The schizophrenic subjects studied were routine cases
from United Kingdom NHS facilities in London and
southern England. They were not selected for having a
positive family history of schizophrenia. An important
implication of this finding is that genetic effects detected
by linkage studies in large multiply affected pedigrees
also apply to routinely treated patients in London and
southern England NHS mental health facilities. The only
gene in the chromosomal region that we implicated by
LD was the Epsin 4 gene. Epsin 4 is a member of a class
of proteins with an “epsin N-terminal homology (ENTH)
domain.” This protein sequence is evolutionarily con-
served and is found in association with other proteins
that participate in clathrin-mediated pit formation and
endocytosis and in vesicle stability (Koshiba et al. 2002).
Enthoprotin is highly enriched on clathrin-coated vesi-
cles isolated from the rat brain and is probably involved
in memory by its effects on reuptake and storage of neuro-
transmitters (Wasiak et al. 2002). Replication studies are
needed to fully establish this new genetic association with
schizophrenia. Etiological base-pair changes present in
the coding and control regions of the Epsin 4 gene can
now be sought by resequencing or mutation screening
of genomic DNA from subjects with schizophrenia who
have inherited the alleles and haplotypes on chromosome
5q33.3 that are associated with schizophrenia.
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